De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase - PubMed (original) (raw)

De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase

P M Vertino et al. Mol Cell Biol. 1996 Aug.

Abstract

Recent studies showing a correlation between the levels of DNA (cytosine-5-)-methyltransferase (DNA MTase) enzyme activity and tumorigenicity have implicated this enzyme in the carcinogenic process. Moreover, hypermethylation of CpG island-containing promoters is associated with the inactivation of genes important to tumor initiation and progression. One proposed role for DNA MTase in tumorigenesis is therefore a direct role in the de novo methylation of these otherwise unmethylated CpG islands. In this study, we sought to determine whether increased levels of DNA MTase could directly affect CpG island methylation. A full-length cDNA for human DNA MTase driven by the cytomegalovirus promoter was constitutively expressed in human fibroblasts. Individual clones derived from cells transfected with DNA MTase (HMT) expressed 1- to 50-fold the level of DNA MTase protein and enzyme activity of the parental cell line or clones transfected with the control vector alone (Neo). To determine the effects of DNA MTase overexpression on CpG island methylation, we examined 12 endogenous CpG island loci in the HMT clones. HMT clones expressing > or = 9-fold the parental levels of DNA MTase activity were significantly hypermethylated relative to at least 11 Neo clones at five CpG island loci. In the HMT clones, methylation reached nearly 100% at susceptible CpG island loci with time in culture. In contrast, there was little change in the methylation status in the Neo clones over the same time frame. Taken together, the data indicate that overexpression of DNA MTase can drive the de novo methylation of susceptible CpG island loci, thus providing support for the idea that DNA MTase can contribute to tumor progression through CpG island methylation-mediated gene inactivation.

PubMed Disclaimer

Cited by

Epigenetic Modification of Cytosines in Hematopoietic Differentiation and Malignant Transformation.
An J, Ko M. An J, et al. Int J Mol Sci. 2023 Jan 15;24(2):1727. doi: 10.3390/ijms24021727. Int J Mol Sci. 2023. PMID: 36675240 Free PMC article. Review.
In vivo stabilization of the Dnmt1 (cytosine-5)- methyltransferase protein.
Ding F, Chaillet JR. Ding F, et al. Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14861-6. doi: 10.1073/pnas.232565599. Epub 2002 Oct 23. Proc Natl Acad Sci U S A. 2002. PMID: 12397175 Free PMC article.
Association of promoter methylation of RASSF1A and KRAS mutations in non-small cell lung carcinoma in Kashmiri population (India).
Din Shah NU, Ali MN, Ganai BA, Mudassar S, Khan MS, Kour J, Waza AA, Rasool MT, Lone AM. Din Shah NU, et al. Heliyon. 2020 Feb 26;6(2):e03488. doi: 10.1016/j.heliyon.2020.e03488. eCollection 2020 Feb. Heliyon. 2020. PMID: 32140600 Free PMC article.
Voluntary Physical Exercise Induces Expression and Epigenetic Remodeling of VegfA in the Rat Hippocampus.
Sølvsten CAE, de Paoli F, Christensen JH, Nielsen AL. Sølvsten CAE, et al. Mol Neurobiol. 2018 Jan;55(1):567-582. doi: 10.1007/s12035-016-0344-y. Epub 2016 Dec 14. Mol Neurobiol. 2018. PMID: 27975171
Effects of ultraviolet B exposure on DNA methylation in patients with systemic lupus erythematosus.
Zhu X, Li F, Yang B, Liang J, Qin H, Xu J. Zhu X, et al. Exp Ther Med. 2013 Apr;5(4):1219-1225. doi: 10.3892/etm.2013.960. Epub 2013 Feb 18. Exp Ther Med. 2013. PMID: 23596493 Free PMC article.

References

1. Cell Growth Differ. 1994 Dec;5(12):1395-402 - PubMed
1. Nat Genet. 1994 Aug;7(4):536-40 - PubMed
1. Cell. 1995 Apr 21;81(2):197-205 - PubMed
1. Trends Genet. 1992 May;8(5):169-74 - PubMed
1. J Biol Chem. 1995 Aug 4;270(31):18543-50 - PubMed

De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase - PubMed (original) (raw)